'Acne medication left me partially blind': Mother prescribed common antibiotics can no longer drive due to blurred vision
Rachel Yeo, 26, from Penarth, Wales, developed high pressure within her skull after taking Minocycline - this caused severe headaches and vision problems. (Source: the Mail online | Health)
Source: the Mail online | Health - January 13, 2014 Category: Consumer Health News Source Type: news

Treatment of Infections Due to Resistant Staphylococcus aureus
This chapter reviews data on the treatment of infections caused by drug-resistant Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA). This review covers findings reported in the English language medical literature up to January of 2013. Despite the emergence of resistant and multidrug-resistant S. aureus, we have seven effective drugs in clinical use for which little resistance has been observed: vancomycin, quinupristin–dalfopristin, linezolid, tigecycline, telavancin, ceftaroline, and daptomycin. However, vancomycin is less effective for infections with MRSA isolates that have a higher MIC w...
Source: Springer protocols feed by Microbiology - October 6, 2013 Category: Microbiology Source Type: news

Help Prevent Intravascular Devices-Related Bloodstream Infections With Minocycline
This method uses a 50:50 THF:water extraction solvent for the preparation of standards and samples.By R. L. Steffen, A. K. Wilson, D.G. Cuttell, M.S. Medrano, L.R. Brewster, and A. Hoffa (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - August 23, 2013 Category: Pharmaceuticals Source Type: news

Newly Published Research Confirms the Efficacy of the Drug Combination...
The completion of preclinical studies demonstrating the neuro-protective and neuro-regenerative properties of minocycline together with NAC bolsters support for human clinical trials. Neurological...(PRWeb July 10, 2013)Read the full story at http://www.prweb.com/releases/2013/7/prweb10825205.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 13, 2013 Category: Pharmaceuticals Source Type: news

Antibiotic Helps Fragile X Kids (CME/CE)
(MedPage Today) -- Treatment with minocycline led to significant, though limited, improvements in children with fragile X syndrome, a randomized study found. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 11, 2013 Category: Pediatrics Source Type: news

Minocycline Show Benefits In Children With Inherited Cause Of Intellectual Disability And Autism
The antibiotic drug minocycline yields "modest" but meaningful improvements in functioning and mood for children with fragile X syndrome (FXS), reports a study in the April Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Three months of treatment with minocycline in children with FXS resulted in greater overall improvement than placebo treatment, according to the study by Dr Mary Jacena S... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 10, 2013 Category: Consumer Health News Tags: Autism Source Type: news

Study investigates minocycline pleurodesis for primary spontaneous pneumothorax
Source: Lancet Area: News According to the results of an open-label RCT conducted in Taiwan, the use of minocycline pleurodesis after simple aspiration is safe and more effective than simple aspiration and drainage only in the treatment for primary spontaneous pneumothorax.   The authors note that simple aspiration and drainage is a standard initial treatment for primary spontaneous pneumothorax. However there is a high rate of recurrence, and they therefore sought to investigate the adjunctive use of minocycline pleurodesis in this setting.  The study, conducted at two hospitals in Taiwan, included 214 pat...
Source: NeLM - News - February 18, 2013 Category: Drugs & Pharmacology Source Type: news

NICE publishes QIPP Medicines Management document
Source: NICE Area: News NICE has published an evidence based document summarising medicines management options for local implementation on identified topics supporting the QIPP medicines use and procurement work stream. The document, which is not formal NICE guidance, covers the following identified topics:   . Laxatives . Renin-angiotensin system drugs . Lipid modifying drugs including ezetimibe . Omega-3 fatty acid supplements . High dose inhaled corticosteroids in asthma . Hypnotics . Low dose antipsychotics in people with dementia . First-choice ant...
Source: NeLM - News - February 1, 2013 Category: Drugs & Pharmacology Source Type: news

Minor Mutations Can Lead To Big Improvements In Antibiotic Resistance
Rice University scientists have found that mutations of small effect can turn out to be game changers in the bacterial fight against antibiotic drugs. The discovery came during an exhaustive, three-year effort to create a mathematical model that could accurately predict how specific mutations allow bacteria like E. coli to adapt to antibiotics like minocycline. The findings are detailed in a study in the Proceedings of the National Academy of Sciences... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 11, 2013 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news

Drug resistance in E. coli: 'Baby steps' can pay off big
Scientists have found that mutations of seemingly small consequence can turn out to be game changers in the bacterial fight against antibiotic drugs. The discovery came during an exhaustive, three-year effort to create a mathematical model that could accurately predict how specific mutations would allow E. coli to ward off attacks by the antibiotic minocycline. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 9, 2013 Category: Science Source Type: news

Drug resistance: 'Baby steps' can pay off big
(Rice University) Rice University scientists have found that mutations of seemingly small consequence can turn out to be game changers in the bacterial fight against antibiotic drugs. The discovery came during an exhaustive, three-year effort to create a mathematical model that could accurately predict how specific mutations would allow E. coli to ward off attacks by the antibiotic minocycline. The findings are detailed in a Dec. 10 study in the Proceedings of the National Academy of Sciences. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2013 Category: Global & Universal Source Type: news